Phoenix Venture Partners

Phoenix Venture Partners, established in 2010, is a venture capital firm headquartered in San Mateo, California, with additional offices in Singapore and Cambridge, Massachusetts. The firm specializes in early-stage investments, focusing on innovative materials science startups across North America, Europe, Asia, and select regions in the Americas. Phoenix Venture Partners invests in a broad range of sectors, including novel materials, optics, energy, healthcare, consumer electronics, and the Internet of Things, among others. The firm's investment strategy is flexible and supportive, offering entrepreneurs assistance with customer and supply chain partnerships, business development, and strategic operational support. Phoenix Venture Partners also collaborates with global corporations to facilitate business development and innovation.

John Chen

Co-Founder and Managing General Partner

Christina Jenkins

Venture Partner

Zach Jonasson

Managing General Partner

Nobuyuki Kambe Ph.D

Co-Founder and Managing General Partner

Nobi Kambe

Managing General Partner

Avinash Kant Ph.D

Partner

Jennifer Wang

CFO

Sheng Peng Ph.D

Venture Partner

47 past transactions

UbiQD

Series B in 2025
UbiQD, LLC is a cleantech materials company based in Los Alamos, New Mexico, that specializes in the production of low-hazard quantum dots and nanocomposites. Founded in 2014, UbiQD aims to make its innovative materials widely accessible for various applications, including agriculture, safety, design, solar energy, lighting, security, and personal care. The company offers UbiGro, a retrofit luminescent film designed to enhance crop growth by optimizing sunlight in greenhouses. UbiQD's low-toxicity quantum dots are engineered to efficiently convert light from one color to another, making them suitable for a range of industries while adhering to safety standards. The firm's strategic location near Los Alamos and Sandia National Laboratory facilitates valuable collaborations with leading scientists, furthering its mission to advance nanomaterial production and application.

Qolab

Series A in 2024
Qolab mission is to build high quality qubits by leveraging the most advanced semiconductor manufacturing processes.

Inkbit

Venture Round in 2024
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of advanced 3D printers. The company has created a next-generation additive manufacturing platform that integrates machine vision and multi-material jetting technologies. By leveraging expertise from MIT-trained scientists and engineers, Inkbit aims to address the challenges of mass-market additive manufacturing. Its innovative approach enables rapid, on-demand production of polymer 3D printed parts, effectively bridging the gap between prototyping and full-scale manufacturing. This capability caters to the needs of industries requiring high precision and speed for complex, multi-material end-use products.

Trace

Pre Seed Round in 2024
Trace is the Canva for AR. The simplest way ever to make AR recordings and experiences for brands, retail, training and more. Partners include teams at Qualcomm, Deutsche Telekom, Lenovo, Telefonica and other fortune 500 companies. Contact us to work together or learn more. Info@Trace3d.app

Nanofiber Quantum Technologies

Convertible Note in 2023
Nanofiber Quantum Technologies is a research and manufacturing company focused on developing innovative hardware for quantum communications. The company specializes in creating quantum computers that utilize nanofibers and advanced engineering techniques. Its expertise encompasses quantum cryptography, quantum communications, and various technologies associated with quantum science aimed at practical applications. By integrating quantum computers into quantum communication networks, Nanofiber Quantum Technologies seeks to advance the field of quantum science and enhance secure communication methods for a range of clients.

FIGUR8

Series A in 2023
FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Ubicept

Seed Round in 2023
Ubicept is a computer vision company that specializes in developing advanced image sensors and machine learning services. By integrating next-generation image sensors with sophisticated computer vision algorithms, Ubicept enables clients to effectively capture and interpret motion across various applications. Their product offerings include photon-counting cameras, edge photon processing technologies, and a private developer portal, all designed to enhance capabilities in sectors such as mobility, robotics, aerospace, and smart manufacturing. With a focus on enabling safe perception and understanding of environments, Ubicept leverages its robust technologies to support a diverse range of industries.

Agrology

Seed Round in 2022
Agrology is an innovative agricultural technology company recognized for its contributions to sustainable farming practices and awarded by the National Science Foundation. As a Public Benefit Corporation, it offers a platform that delivers real-time data to growers, enabling them to assess the ecological and agronomic effects of regenerative practices. The company specializes in monitoring soil health, microbial activity, carbon cycles, nitrous oxide emissions, net ecosystem exchange, and microclimatic conditions. This data equips farmers to link their regenerative practices with documented reductions in greenhouse gas emissions and other ecological benefits. Agrology's services are trusted by top growers, researchers, and global consumer packaged goods brands, and the company maintains offices in Alexandria, Virginia, and Salinas, California.

Green Theme Technologies

Series B in 2022
Green Theme Technologies Inc is a developer of environmentally-friendly chemical technology focused on the finishing of textiles and nonwovens. Founded in 2012 and based in Rio Rancho, New Mexico, the company aims to innovate in the textile industry by creating products that surpass the performance of existing technologies while also eliminating water usage and reducing pollution. Green Theme Technologies is committed to sustainable practices and seeks to transform textile finishing processes through its advanced, dry technology solutions.

Profluent

Venture Round in 2022
Profluent Bio is an artificial intelligence-driven protein design company focused on creating innovative proteins that overcome existing industry challenges. The company integrates advanced generative AI models with real-world laboratory characterization to optimize protein development. By employing machine learning techniques, Profluent Bio is able to read and write biomolecules, facilitating advancements in both human health and industrial applications. This approach supports biotechnology research and aims to enhance the effectiveness of protein-based solutions across various sectors.

Biotia

Series A in 2022
Biotia, Inc. is a health technology company based in New York, founded in 2016. It specializes in developing software and laboratory technologies that leverage next-generation DNA sequencing and artificial intelligence to enhance infectious disease discovery and management. By providing tailored microbial surveillance, Biotia's innovative solutions enable clinicians and researchers to identify and mitigate pathogens effectively, thereby reducing hospital-acquired infections and improving patient outcomes. The company's technology empowers healthcare professionals to guide treatment decisions proactively, ultimately aiming to prevent illnesses before they occur.

Autonomic Materials

Venture Round in 2022
Autonomic Materials, Inc. is a manufacturer specializing in self-healing solutions for the coatings industry, primarily focusing on corrosion-resistant chemicals that repair coating damage at the micron level. Founded in 2005 and based in Champaign, Illinois, the company offers a range of microencapsulated additives, including dual capsule systems and single capsule systems, designed for various applications. These products provide essential protection for materials such as metals, wood, concrete, plastics, and composites, and are utilized across multiple sectors, including alternative energy, industrial maintenance, military equipment, infrastructure, oil and gas, transportation, and consumer paints. Autonomic Materials' innovative solutions enable coatings, adhesives, and composites to respond to damage automatically, enhancing the durability and performance of structures like cars, bridges, and ships.

Eclipse BioInnovations

Series A in 2022
Eclipse BioInnovations is a prominent RNA genomics company established in 2017, leveraging innovative technology developed at the University of California, San Diego. The company specializes in advanced RNA genomics platforms aimed at enhancing RNA medicines and scientific research. Its founders introduced eCLIP, a highly efficient CLIP-seq technology for identifying RNA binding protein gene partners and gene maps. Eclipse BioInnovations offers a comprehensive suite of RNA genomics technologies, including eCLIP-RBP for mapping RNA binding proteins, miR-eCLIP for analyzing the miR-interactome, m6A-eCLIP for studying RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for streamlining CRISPR library preparation. These products are available as services and kits for biopharmaceutical companies and academic researchers and can be customized to meet specific client needs. By providing these specialized genomics-based products and services, Eclipse BioInnovations empowers scientists to accelerate their research and develop effective therapies for various human diseases.

InVivo AI

Seed Round in 2021
InVivo AI is a Montreal-based company founded in 2017 that specializes in leveraging artificial intelligence to enhance pharmaceutical research and development, with a particular focus on preclinical toxicology. The company has developed advanced AI methods for molecular representation, structure and ligand-based de novo design, and multiparameter optimization, enabling the creation of novel chemistry to address complex biological challenges.

Xandar Kardian

Series A in 2021
Xandar Kardian specializes in advanced presence detection and occupancy counting solutions for smart building applications. The company has developed a patented occupancy count system that uniquely utilizes radar technology to accurately count individuals in open spaces, overcoming limitations of traditional camera-based systems. By analyzing micro-vibration patterns from the body, such as chest movement and heartbeats, Xandar Kardian achieves continuous and precise measurements of vital signs, including resting heart rate and respiratory rate. This technology facilitates occupant wellness monitoring in various environments, including offices, factories, hospitals, nursing homes, and residential settings, without the need for cameras or wearable devices. The company's innovative approach ensures accurate people counting while maintaining privacy and security.

FibreCoat

Venture Round in 2021
FibreCoat GmbH specializes in manufacturing thermoplastic-coated glass fibres, primarily serving the automotive and consumer sectors. The company's unique direct coating process enables cost savings and reduced production times while enhancing product specifications for fibre composite applications. FibreCoat's offerings include metal-coated fibres designed for electromagnetic interference shielding, heat sinks, reinforcement of cast aluminium parts, and conductive yarns in smart textiles.

Inkbit

Series B in 2021
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of advanced 3D printers. The company has created a next-generation additive manufacturing platform that integrates machine vision and multi-material jetting technologies. By leveraging expertise from MIT-trained scientists and engineers, Inkbit aims to address the challenges of mass-market additive manufacturing. Its innovative approach enables rapid, on-demand production of polymer 3D printed parts, effectively bridging the gap between prototyping and full-scale manufacturing. This capability caters to the needs of industries requiring high precision and speed for complex, multi-material end-use products.

FIGUR8

Series A in 2021
FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Green Theme Technologies

Venture Round in 2021
Green Theme Technologies Inc is a developer of environmentally-friendly chemical technology focused on the finishing of textiles and nonwovens. Founded in 2012 and based in Rio Rancho, New Mexico, the company aims to innovate in the textile industry by creating products that surpass the performance of existing technologies while also eliminating water usage and reducing pollution. Green Theme Technologies is committed to sustainable practices and seeks to transform textile finishing processes through its advanced, dry technology solutions.

Cotsworks

Venture Round in 2021
Cotsworks is a manufacturer that specializes in rugged optical components designed for commercial, military, aerospace, and industrial applications. Established in 2006 and headquartered in Cleveland, Ohio, the company focuses on providing solutions that operate effectively in harsh environments. Cotsworks facilitates the transition from copper to optical networking and offers advanced subsystems for navigation, threat detection, and control systems. By serving the industrial-military and commercial aerospace sectors, the company aims to enhance operational efficiency and reliability.

L7 Informatics

Series B in 2021
L7 Informatics, Inc. is a provider of integrated scientific data and analytics solutions designed to enhance the management and analysis of scientific data across various industries, including therapeutics, diagnostics, and research. The company offers the L7 Enterprise Science Platform (L7|ESP®), a comprehensive platform that streamlines data integration, automates workflows, and fosters collaboration among scientists and researchers. By contextualizing data and eliminating silos, L7|ESP® facilitates the digitalization of scientific processes, ultimately accelerating discoveries and driving innovation. The platform aims to improve operational efficiencies, enhance compliance, and reduce costs, thereby optimizing the overall scientific process and enabling breakthroughs in drug discovery, development, and manufacturing.

Absci

Series E in 2020
Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

WaveDyn Vision

Venture Round in 2020
WaveDyn Vision is an early-stage medical device company with innovative wavefront diagnostic technology for use in the vision care industry. It plans to leverage its proprietary dynamic wavefront measurement technology to yield new insights into assessing visual performance, advancing treatment options, and improving the quality of life for the visually impaired. The company was founded in 2019 and is based in Albuquerque, New Mexico.

WaveFront Dynamics

Series A in 2020
WaveFront Dynamics is a medical device company specializing in advanced wavefront diagnostic technology for the vision care industry. The company develops instruments that assess the visual performance of the human eye by measuring dynamic changes over time, rather than providing a single snapshot. This innovative approach allows for a comprehensive evaluation of the eye, enabling healthcare professionals to enhance treatment planning for complex visual dysfunctions. Through its sophisticated dynamic wavefront measurement capabilities, WaveFront Dynamics aims to improve patient outcomes in ophthalmic care.

Micropore

Series C in 2020
Micropore manufactures reactive plastics which incorporate various powders into a molded matrix. The company's first product uses a CO2 adsorbent powder which is formed into a cartridge to create a revolutionary CO2 adsorbent system used in rebreathing and life support applications. The patented technology is the first major advance in CO2 adsorbent technology in over 100 years, providing superior performance advantages over existing granular adsorbents. It was founded in March of 1997 and is based in Elkton, Maryland.

Crop Enhancement

Series B in 2020
Crop Enhancement LLC is an early-stage specialty materials company based in San Jose, California, founded in 2011. The company focuses on developing innovative anchoring and controlled-release formulation technologies for agricultural chemicals. Its advanced agrochemical formulations utilize environmentally friendly chemistry to enhance crop yields and profitability while minimizing the reliance on synthetic pesticides. Crop Enhancement's products include proprietary films that modify plant surfaces, improving resistance to pests and diseases. This approach not only supports sustainable farming practices but also enables precise delivery of active ingredients and fertilizers, ultimately benefiting growers through increased efficiency and reduced chemical use.

Absci

Series D in 2020
Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

BroadSpot Imaging Corporation

Series A in 2018
BroadSpot Imaging Corporation focuses on developing diagnostic medical devices for eye care, specifically in the area of retinal imaging. The company employs advanced imaging technologies and compact, cloud-connected electronics to create cost-effective handheld instruments that replace traditional bulky and expensive diagnostic tools. By integrating AI and machine learning applications, BroadSpot Imaging aims to enhance the efficiency and accessibility of eye care services. Their innovations are designed to meet the growing demand for high-quality diagnostics, particularly as the population ages, allowing eye care professionals to serve more patients effectively and affordably across various medical settings.

Absci

Series C in 2018
Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

Comera Life Sciences

Series A in 2018
Comera Life Sciences is a biotechnology company focused on advancing formulation science to enhance the delivery of biologic medicines. It specializes in transforming essential biologic therapies from intravenous to subcutaneous administration, utilizing its proprietary SQore platform. This platform not only optimizes existing subcutaneous biologics but also aims to create biosimilar versions of these products. Comera's technology incorporates patented, FDA-friendly excipients that improve the stability, immunogenicity, and production efficiency of therapeutic biologics. The company collaborates with pharmaceutical and biotechnology partners to apply its innovative solutions to their biologic medicines, ultimately striving to make life-saving treatments easier to administer for fragile patients.

NBD Nanotechnologies

Series B in 2017
NBD Nanotechnologies, Inc. is a manufacturer of surface wettability coatings and additives designed to enhance the performance of various materials. Founded in 2012 and headquartered in Lexington, Massachusetts, the company offers a diverse product portfolio that includes RepelShell, RepelFlex Antimicrobial, RepelFlex Soft-Touch, NanoGlue, RepelFlex Hard-Coat, Invisiprint, and RepelFlex Leather. These products are engineered to modify surface properties, improving functionalities such as heat transfer, condensation control, fog capture, de-misting, and anti-scaling performance. NBD Nanotechnologies focuses on providing innovative solutions that create ultra-durable and functional surface characteristics for glass and plastic materials, catering to a range of commercial partners.

Furcifer

Series A in 2017
Furcifer Inc. is a technology company based in Menlo Park, California, established in 2015. The firm specializes in the development and manufacturing of next-generation electrochromic films, also known as smart films. These films are designed to enhance traditional glass by enabling control over light and heat transmission, making them applicable in various sectors including automotive, architecture, and electronic displays. Furcifer's technology allows customers to create smart windows that can store solar energy, providing an innovative solution for energy efficiency. The company is venture-backed and operates within the dynamic landscape of Silicon Valley startups.

BroadSpot Imaging Corporation

Series A in 2017
BroadSpot Imaging Corporation focuses on developing diagnostic medical devices for eye care, specifically in the area of retinal imaging. The company employs advanced imaging technologies and compact, cloud-connected electronics to create cost-effective handheld instruments that replace traditional bulky and expensive diagnostic tools. By integrating AI and machine learning applications, BroadSpot Imaging aims to enhance the efficiency and accessibility of eye care services. Their innovations are designed to meet the growing demand for high-quality diagnostics, particularly as the population ages, allowing eye care professionals to serve more patients effectively and affordably across various medical settings.

Absci

Series B in 2017
Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

C3Nano

Series D in 2017
C3Nano is a company that specializes in developing transparent conductive inks and films, serving as direct replacements for indium tin oxide (ITO). Founded in 2010 and headquartered in Hayward, California, C3Nano is recognized as a leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire solution-based inks, primarily for the touch sensor and display industry. Its products are designed to enhance the touchscreen and digital display experience by providing superior scratch resistance, durability, and optical clarity. Additionally, these inks and films are compatible with a wide range of substrates and processing techniques, enabling clients to address the growing demand for flexible touch sensor applications. The company has established a strong manufacturing presence in Korea and has raised significant funding to advance its ink formulations and production capabilities.

Crop Enhancement

Series B in 2016
Crop Enhancement LLC is an early-stage specialty materials company based in San Jose, California, founded in 2011. The company focuses on developing innovative anchoring and controlled-release formulation technologies for agricultural chemicals. Its advanced agrochemical formulations utilize environmentally friendly chemistry to enhance crop yields and profitability while minimizing the reliance on synthetic pesticides. Crop Enhancement's products include proprietary films that modify plant surfaces, improving resistance to pests and diseases. This approach not only supports sustainable farming practices but also enables precise delivery of active ingredients and fertilizers, ultimately benefiting growers through increased efficiency and reduced chemical use.

Nohms Technologies

Series B in 2016
NOHMs Technologies, Inc. specializes in the development of advanced lithium-sulfur and lithium-ion batteries, targeting a range of applications from spacecraft to electric vehicles. The company focuses on manufacturing key components such as electrodes, electrolytes, and separators, while also offering innovative solutions for secondary manufacturers. Established in 2010 and headquartered in Rochester, New York, NOHMs Technologies aims to enhance battery performance and safety through its proprietary NanoLyte Electrolyte solutions, which utilize advanced ionic liquid materials. This approach allows for improved energy density and runtime at a reduced cost, catering to the growing demands of consumer electronics and electric vehicle markets.

Amber Molecular

Series A in 2016
Amber Molecular Inc. is a Toronto-based company established in 2017 that specializes in the development of innovative materials for organic light-emitting diodes (OLEDs). The company focuses on creating new light-emitting materials that enhance performance in the display sector and other applications. Their patented technologies feature bright, rare earth metal-free OLEDs that produce a range of colors from orange to infrared. Notably, Amber Molecular's materials exhibit less perceived peak shifting due to their narrow emissions, which eliminates the need for filters and contributes to more cost-effective OLED applications.

Absci

Series A in 2016
Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

Sentinel Monitoring Systems

Series A in 2015
Sentinel Monitoring Systems, Inc. is a company specializing in the development of microbial monitoring systems tailored for the life sciences industry. Based in Tucson, Arizona, it offers a range of products including the MOBA, an online bioburden monitoring system for ultra-pure and purified water systems; the ASP, an aseptic auto-sampler that collects random and scheduled samples; and the OES, an online endotoxin system that automates endotoxin testing. Additionally, the company features Fountain Flow Cytometry, which provides near-real-time quantification of total bioburden. Sentinel Monitoring Systems focuses on enhancing quality control through innovative technology, enabling organizations to detect microbial contamination swiftly and improve their manufacturing processes. Founded in 2014, the company continues to develop advanced solutions aimed at ensuring microbial control within the life sciences sector.

C3Nano

Series C in 2014
C3Nano is a company that specializes in developing transparent conductive inks and films, serving as direct replacements for indium tin oxide (ITO). Founded in 2010 and headquartered in Hayward, California, C3Nano is recognized as a leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire solution-based inks, primarily for the touch sensor and display industry. Its products are designed to enhance the touchscreen and digital display experience by providing superior scratch resistance, durability, and optical clarity. Additionally, these inks and films are compatible with a wide range of substrates and processing techniques, enabling clients to address the growing demand for flexible touch sensor applications. The company has established a strong manufacturing presence in Korea and has raised significant funding to advance its ink formulations and production capabilities.

NBD Nanotechnologies

Series A in 2014
NBD Nanotechnologies, Inc. is a manufacturer of surface wettability coatings and additives designed to enhance the performance of various materials. Founded in 2012 and headquartered in Lexington, Massachusetts, the company offers a diverse product portfolio that includes RepelShell, RepelFlex Antimicrobial, RepelFlex Soft-Touch, NanoGlue, RepelFlex Hard-Coat, Invisiprint, and RepelFlex Leather. These products are engineered to modify surface properties, improving functionalities such as heat transfer, condensation control, fog capture, de-misting, and anti-scaling performance. NBD Nanotechnologies focuses on providing innovative solutions that create ultra-durable and functional surface characteristics for glass and plastic materials, catering to a range of commercial partners.

Imprint Energy

Series A in 2014
Imprint Energy, Inc. is a developer of innovative zinc-based rechargeable battery technology, focusing on creating flexible and low-cost battery solutions for portable electronics. Founded in 2010 and based in Alameda, California, the company has introduced its ZincPoly battery technology, which overcomes traditional limitations of zinc-based batteries, thus facilitating the production of rechargeable options. Imprint Energy's batteries are designed for various applications, including mobile accessories, compact wireless devices, wearable technology, health and fitness monitoring, and medical devices. The company’s unique electrochemistry system allows for thin, flexible, and high-energy-density batteries, produced through a scalable, print-based manufacturing process. This technology aims to deliver lithium-like performance at lower costs while enhancing safety and eliminating form factor constraints, addressing the evolving energy needs of modern electronic devices.

Autonomic Materials

Series B in 2012
Autonomic Materials, Inc. is a manufacturer specializing in self-healing solutions for the coatings industry, primarily focusing on corrosion-resistant chemicals that repair coating damage at the micron level. Founded in 2005 and based in Champaign, Illinois, the company offers a range of microencapsulated additives, including dual capsule systems and single capsule systems, designed for various applications. These products provide essential protection for materials such as metals, wood, concrete, plastics, and composites, and are utilized across multiple sectors, including alternative energy, industrial maintenance, military equipment, infrastructure, oil and gas, transportation, and consumer paints. Autonomic Materials' innovative solutions enable coatings, adhesives, and composites to respond to damage automatically, enhancing the durability and performance of structures like cars, bridges, and ships.

Vixar

Series B in 2012
Vixar Inc. is a manufacturer of short wavelength vertical cavity surface emitting laser (VCSEL) and LED-based optical components and subassemblies, primarily serving sensor and device applications. Founded in 2005 and based in Plymouth, Minnesota, Vixar provides high-performance, cost-effective VCSEL products that emit wavelengths ranging from 660 to 1850 nm. The company's offerings enhance the performance, size, and energy efficiency of optoelectronic devices across various sectors, including biomedical, industrial, military, automotive, office products, and consumer industries. Vixar was established by Dr. Klein Johnson and Dr. Mary Hibbs-Brenner, who played significant roles in developing VCSEL technology at Honeywell for high-speed fiber optic data communications. In 2018, Vixar became a subsidiary of OSRAM Licht AG.

C3Nano

Series B in 2012
C3Nano is a company that specializes in developing transparent conductive inks and films, serving as direct replacements for indium tin oxide (ITO). Founded in 2010 and headquartered in Hayward, California, C3Nano is recognized as a leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire solution-based inks, primarily for the touch sensor and display industry. Its products are designed to enhance the touchscreen and digital display experience by providing superior scratch resistance, durability, and optical clarity. Additionally, these inks and films are compatible with a wide range of substrates and processing techniques, enabling clients to address the growing demand for flexible touch sensor applications. The company has established a strong manufacturing presence in Korea and has raised significant funding to advance its ink formulations and production capabilities.

Senova Systems

Series B in 2012
Senova Systems, Inc. is a company based in Sunnyvale, California, that specializes in the development, manufacture, and sale of innovative pH measurement systems. Founded in 2007, Senova focuses on its patented calibration-free pHit™ pH sensor platform, which employs non-glass electrodes and features a wet-dry reversible design. This solid-state sensor technology represents a significant advancement in pH measurement, eliminating the need for user calibration and enabling novel applications across various sectors, including life sciences, food and beverage, dairy, water, and consumer products. By integrating advanced materials and proprietary microelectronics, Senova aims to enhance the precision and usability of pH sensors, paving the way for technological innovations previously unattainable with traditional glass electrodes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.